Physician profile
Allison Petznick
NPI 1609949205
$2,814.24
in general payments reported to CMS, 2019-2025
37 companies · $477 in 2025
The $477 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $81.26 · 2021: $188 · 2022: $450 · 2023: $641 · 2024: $543 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $523.29 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $465.76 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $271.29 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $163.74 | 2019-2024 | Mounjaro, Jardiance |
| Tandem Diabetes Care, INC. | $111.69 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Pfizer INC. | $93.30 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $81.75 | 2023-2025 | Gvoke Hypopen |
| Exact Sciences Corporation | $81.55 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $80.68 | 2023-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $77.17 | 2022-2024 | Rexulti |
| Dexcom, INC. | $65.96 | 2022-2023 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.74 | 2019-2024 | Jardiance |
| Abbott Laboratories | $61.60 | 2022-2025 | Freestyle Libre 3 |
| Amgen INC. | $54.91 | 2019-2023 | Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $54.43 | 2021-2023 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Petznick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.